V K Mehta

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 48:1483-7. 2000
  2. ncbi request reprint Unsuspected abnormalities noted on CT treatment-planning scans obtained for breast and chest wall irradiation
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 49:723-5. 2001
  3. ncbi request reprint Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    J Gastrointest Surg 5:27-35. 2001
  4. ncbi request reprint Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA 94305, USA
    Arch Surg 136:65-9. 2001
  5. ncbi request reprint Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, California 94305, USA
    Am J Clin Oncol 24:155-9. 2001
  6. ncbi request reprint Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, California 94305, USA
    Dis Colon Rectum 44:52-8. 2001
  7. ncbi request reprint Pancreatic tumors show high levels of hypoxia
    A C Koong
    Department Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 48:919-22. 2000
  8. ncbi request reprint Is diagnostic review of radiotherapy-planning CT scans important in the conformal therapy era?
    M C Smitt
    Department of Radiation Oncology, Stanford Hospital, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA 94305, USA
    AJR Am J Roentgenol 177:521-4. 2001

Detail Information

Publications8

  1. ncbi request reprint Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 48:1483-7. 2000
    ..To assess the toxicity and clinical benefit from adjuvant chemoradiotherapy consisting of protracted venous infusion 5-fluorouracil (5-FU) and concomitant radiotherapy in patients with resected pancreatic cancer...
  2. ncbi request reprint Unsuspected abnormalities noted on CT treatment-planning scans obtained for breast and chest wall irradiation
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 49:723-5. 2001
    ..In this paper, we review the incidental findings discovered on a careful review of these scans...
  3. ncbi request reprint Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    J Gastrointest Surg 5:27-35. 2001
    ..Greater patient accrual and longer follow-up are needed to more accurately assess its future role in therapy...
  4. ncbi request reprint Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA 94305, USA
    Arch Surg 136:65-9. 2001
    ..004). CONCLUSIONS: Adjuvant chemoradiotherapy for carcinoma of the ampulla of Vater is well tolerated and might improve control of this disease in patients with unfavorable features...
  5. ncbi request reprint Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, California 94305, USA
    Am J Clin Oncol 24:155-9. 2001
    ..The method of 5-FU administration (bolus versus PVI) did not change the RT treatment intensity, experienced toxicity, or overall survival...
  6. ncbi request reprint Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer
    V K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, California 94305, USA
    Dis Colon Rectum 44:52-8. 2001
    ..CONCLUSION: Our experience suggests that preoperative chemoradiotherapy is well tolerated, down-stages tumors, and sterilizes regional lymph nodes...
  7. ncbi request reprint Pancreatic tumors show high levels of hypoxia
    A C Koong
    Department Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 48:919-22. 2000
    ..Because of the dismal outcomes of conventional therapies for pancreatic carcinomas, we postulated that hypoxia may exist within these tumors...
  8. ncbi request reprint Is diagnostic review of radiotherapy-planning CT scans important in the conformal therapy era?
    M C Smitt
    Department of Radiation Oncology, Stanford Hospital, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA 94305, USA
    AJR Am J Roentgenol 177:521-4. 2001
    ..Detailed CT scans are often acquired during the radiotherapy planning process. This study was performed to determine the incidence of important benign and cancer-related CT findings on these scans...